I am pleased to introduce the latest article, “Using Serologic Screening To Identify And Monitor At-Risk Charcot Patients,” in our CE series. This series, brought to you by the North American Center for Continuing Medical Education, consists of regular CE activities that qualify for one continuing education contact hour (.1 CEU). Readers will not be required to pay a processing fee for this course.
Timely diagnosis and subsequent treatment are essential when it comes to Charcot neuroarthropathy. With this in mind, Molly Judge, DPM, a Fellow of the American College of Foot and Ankle Surgeons, and a certified nuclear medicine technologist, provides a thorough overview of serologic screening, with a specific emphasis on the use of the erythrocyte sedimentation rate and C-reactive protein.
At the end of this article, you’ll find a 10-question exam. Please mark your responses on the enclosed postcard and return it to HMP Communications. This course will be posted on Podiatry Today’s Web site (www.podiatrytoday.com) roughly one month after the publication date. I hope this CE series contributes to your clinical skills.
Jeff A. Hall
INSTRUCTIONS: Physicians may receive one continuing education contact hour (.1 CEU) by reading the article on pg. 76 and successfully answering the questions on pg. 82. Use the enclosed card provided to submit your answers or fax the form to NACCME at (610) 560-0502.
ACCREDITATION: The North American Center for Continuing Education (NACCME) is approved by the Council on Podiatric Medical Education as a sponsor of continuing education in podiatric medicine.
DESIGNATION: This activity is approved for 1 continuing education contact hour or .1 CEU.
DISCLOSURE POLICY: All faculty participating in Continuing Education programs sponsored by the NACCME are expected to disclose to the audience any real or apparent conflicts of interest related to the content of their presentation.
DISCLOSURE STATEMENTS: Dr. Judge has disclosed that she has no significant financial relationship with any organization that could be perceived as a real or apparent conflict of interest in the context of the subject of her presentation.
GRADING: Answers to the CE exam will be graded by the NACCME. Within 60 days, you will be advised that you have passed or failed the exam. A score of 70 percent or above will comprise a passing grade. A certificate will be awarded to participants who successfully complete the exam.
TARGET AUDIENCE: Podiatrists.
RELEASE DATE: August 2004.
EXPIRATION DATE: August 31, 2005.
LEARNING OBJECTIVES: At the conclusion of this activity, participants should be able to:
• describe how the C-reactive protein (CRP) correlates with the occurrence and resolution of clinical disease;
• discuss possible non-infectious reasons for CRP elevation;
• discuss the diagnostic merits of the erythrocyte sedimentation rate (ESR); and
• compare and contrast the CRP with the ESR.
Sponsored by the North American Center for Continuing Medical Education.